Nikolaos Stergiopoulos

Nationality: Greek, Swiss

EPFL STI IBI-STI LHTC
MED 3 2326 (Bâtiment MED)
Station 9
1015 Lausanne

EPFL STI IBI-STI LHTC
MED 3 2326 (Bâtiment MED)
Station 9
1015 Lausanne

EPFL STI IBI-STI LHTC
MED 3 2326 (Bâtiment MED)
Station 9
1015 Lausanne

Expertise

Arterial wall mechanics Vascular remodeling Atherogenesis and restenosis Arterial wave propagation Heart-arterial system interaction Cardiac mechanics Angioplasty & stenting Implantable devices

Expertise

Arterial wall mechanics Vascular remodeling Atherogenesis and restenosis Arterial wave propagation Heart-arterial system interaction Cardiac mechanics Angioplasty & stenting Implantable devices

Mission

The goal of the Laboratory of Hemodynamics and Cardiovascular Technology (LHCT) is to become a leading laboratory in the study of blood flow in relation to cardiovascular disease and to contribute to the advancement of cardiovascular technology through active transfer of our know-how to the clinic and to the medical technology sector.
Education MTE, Managing the Technology Enterprise Program (2000), IMD, Lausanne Ph.D. in Biomedical Engineering & Engineering Mechanics (1990) Iowa State University, Ames, Iowa. MS in Biomedical Engineering (1987) Iowa State University, Ames, Iowa. Diploma in Mechanical Engineering (1985) National Technical University of Athens. Professional Activities 2002 - present: Professor and director of LHTC 2010 - present: Founder and director of Rheon Medical SA, Préverenges, Switzerland 2008 - present: Founder and director of Antlia S.A., PSE-C, EPFL campus, Switzerland 1998 - 2007: Founder and Scientific Director of EndoArt S.A., Lausanne, Switzerland 1996 - 2002: Assistant professor at the Biomedical Engineering Laboratory, Swiss Federal Institute of Technology, Lausanne, Switzerland. 1991 - 1996: Research Associate at Swiss Federal Institute of Technology - Lausanne 1990 - 1991: Lecturer, Iowa State University